









Markets
/
Stocks
/
nasdaq-evh
/

Evolent Health Inc

EVH

2.170USD

-0.040-1.81%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

120.98MMarket Cap

LossP/E TTM



Evolent Health Inc

2.170

-0.040-1.81%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Evolent Health Inc

Currency: USD Updated: 2026-03-27

Key Insights

Evolent Health Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 60 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.89.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Evolent Health Inc's Score

Industry at a Glance

Industry Ranking

60 / 208

Overall Ranking

161 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Evolent Health Inc Highlights

StrengthsRisks

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 1.88B.

Overvalued

The company’s latest PE is -0.44, at a high 3-year percentile range.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 10.90K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.77.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

5.893

Target Price

+147.59%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Evolent Health Inc is 6.38, ranking 153 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 468.72M, representing a year-over-year decrease of 27.50%, while its net profit experienced a year-over-year decrease of 1301.70%.

Score

Industry at a Glance

Previous score

6.38

Change



Financials

4.90

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.28

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.42

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.18

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.14

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Evolent Health Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Evolent Health Inc is 8.39, ranking 22 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.44, which is 0.00% below the recent high of -0.44 and -40082.60% above the recent low of -175.04.

Score

Industry at a Glance

Previous score

8.39

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 60/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Evolent Health Inc is 8.38, ranking 43 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 9.75, with a high of 16.00 and a low of 6.00.

Score

Industry at a Glance

Previous score

8.38

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

5.893

Target Price

+166.64%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Evolent Health Inc

EVH

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Evolent Health Inc is 5.58, ranking 176 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 3.21 and the support level at 1.70, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.77

Change

-0.19

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(5)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.133

Sell

RSI(14)

29.699

Sell

STOCH(KDJ)(9,3,3)

7.995

Oversold

ATR(14)

0.191

High Vlolatility

CCI(14)

-109.044

Sell

Williams %R

94.286

Oversold

TRIX(12,20)

-1.072

Sell

StochRSI(14)

26.180

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

2.256

Sell

MA10

2.459

Sell

MA20

2.821

Sell

MA50

3.018

Sell

MA100

3.623

Sell

MA200

6.422

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Evolent Health Inc is 10.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 136.65%, representing a quarter-over-quarter decrease of 1.19%. The largest institutional shareholder is The Vanguard, holding a total of 8.89M shares, representing 7.97% of shares outstanding, with 14.34% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Cadian Capital Management LP

11.73M

+12.51%

The Vanguard Group, Inc.

Star Investors

10.95M

+0.42%

BlackRock Institutional Trust Company, N.A.

7.85M

+1.36%

Morgan Stanley & Co. LLC

7.49M

+1.80%

UBS Financial Services, Inc.

3.40M

+21.01%

Rubicon Founders, LLC

5.82M

Engaged Capital, LLC

5.66M

-3.25%

D. E. Shaw & Co., L.P.

2.74M

+30.10%

State Street Investment Management (US)

2.97M

+0.05%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Evolent Health Inc is 4.30, ranking 107 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.34. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Evolent Health Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.